555 related articles for article (PubMed ID: 21368371)
1. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
Recht A
Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
[TBL] [Abstract][Full Text] [Related]
2. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
3. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
4. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
6. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
8. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes?
Dominici L; Golshan M
Minerva Chir; 2010 Oct; 65(5):547-54. PubMed ID: 21081866
[TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
11. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
13. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
Shahar KH; Hunt KK; Thames HD; Ross MI; Perkins GH; Kuerer HM; Strom EA; McNeese MD; Meric F; Schechter NR; Sahin AA; Middleton LP; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1074-9. PubMed ID: 15234041
[TBL] [Abstract][Full Text] [Related]
15. Is axillary dissection necessary after positive sentinel node biopsy? Yes!
Morrow M
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):74S-76S. PubMed ID: 11599907
[TBL] [Abstract][Full Text] [Related]
16. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
17. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of sentinel node biopsy in the previously treated breast.
Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
[TBL] [Abstract][Full Text] [Related]
20. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.
Chen JJ; Wu J
Crit Rev Oncol Hematol; 2011 Sep; 79(3):293-301. PubMed ID: 20663684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
